|Organovo Holdings, Inc.|
5871 Oberlin Drive
United States - Map
Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The companys 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.
|Mr. Keith Murphy ,
Chairman, Chief Exec. Officer and Pres
|Mr. Barry D. Michaels ,
Chief Financial Officer, Principal Accounting Officer and Sec.
|Dr. Sharon Collins Presnell Ph.D.,
Chief Technology Officer and Exec. VP of R&D
|Mr. Michael Renard ,
Exec. VP of Commercial Operations
|Dr. Eric Michael David M.D., J.D., Ph.D.,
Chief Strategy Officer
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|